Smith & Nephew's (SNN) STITCH Study Outcome Encouraging
Zacks Investment Research | Oct 09, 2019 10:07PM ET
Smith & Nephew (LON:SN)plc (NYSE:SNN) recently announced favorable one-year results of the STITCH Study evaluating its NOVOSTITCH Meniscal Repair System.
This can be considered a major step toward the company’s commitment of strengthening its Global Sports Medicine and ENT segment.
Study Results in Details
The STITCH Study is the first prospective clinical trial to assess the proficiency of repairing Horizontal Cleavage Tears— one of the most common meniscal tears that affects nearly one-third of patients with this injury.
The outcome of the study highlighted a success rate of 91.7% (reoperation rate of only 8.3%) and a drastic improvement in knee function in all Patient Reported Outcomes including KOOS, IKDC, Lysholm and Tegner scores.
The NOVOSTITCH Meniscal Repair System caters to complex meniscal tear patterns which are not properly served by the other repair systems currently available in the market.
For two years after surgery, the STITCH Study will continue to follow up patients.
The NOVOSTITCH Meniscal Repair System, available only in the United States, is a crucial addition to Smith & Nephew's portfolio of All Tears, All Repairs meniscal repair systems.
Recent Developments
Lately, Smith & Nephew has been investing in developments which are expected to boost its Global Sports Medicine segment.
In September 2019, Smith & Nephew launched its LENS 4K Surgical Imaging System which is a high-tech visualization platform designed for end-to-end 4K imaging.This should enable surgeons to perform complex arthroscopic procedures.
Price Performance
In the past three months, the company’s shares have gained 6.8% against the Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.